Antibiotic Resistance Trends and Prescribing Patterns in Pediatric Non-Typhoidal Salmonella Enteritis: A 10-Year Single-Centre Retrospective Study.

IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES
Infection and Drug Resistance Pub Date : 2026-09-28 eCollection Date: 2026-01-01 DOI:10.2147/IDR.S632613
Xing Liao, Jiajia Lu, Rongrong Yang, Ling Wu, Chengyi Wang
{"title":"Antibiotic Resistance Trends and Prescribing Patterns in Pediatric Non-Typhoidal <i>Salmonella</i> Enteritis: A 10-Year Single-Centre Retrospective Study.","authors":"Xing Liao, Jiajia Lu, Rongrong Yang, Ling Wu, Chengyi Wang","doi":"10.2147/IDR.S632613","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Non-typhoidal <i>Salmonella</i> (NTS) enteritis is a major cause of infectious diarrhoea in children and increasing antibiotic resistance is limiting treatment effectiveness. There is limited longitudinal data on resistance development and on how well prescribing practices align with resistance patterns in hospitalised children. This study aimed to assess trends in antibiotic resistance, the prevalence of multidrug resistance (MDR), and treatment concordance over a decade from a single Chinese Centre.</p><p><strong>Methods: </strong>The study included children with microbiologically confirmed NTS enteritis with available antibiotic susceptibility data. Resistance rates for 11 antibiotics were calculated, and temporal trends were analysed using the Cochran-Armitage trend test. MDR was defined as resistance to three or more antibiotic classes. Treatment concordance was assessed by comparing the empiric antibiotic class with in vitro susceptibility results.</p><p><strong>Results: </strong>Of 486 records reviewed, 422 children were included. Infants under one year included 69.4% of cases. <i>S</i>. <i>Typhimurium</i> was the predominant serotype (58.8%). Ampicillin resistance was highest at 76.3%, followed by ampicillin/sulbactam (61.8%) and co-trimoxazole (34.8%). Ceftriaxone resistance was 28.4%. Ampicillin/sulbactam resistance increased significantly over the decade (44.4% to 65.3%; p = 0.010), while ciprofloxacin resistance declined (44.4% to 4.0%; p = 0.005). MDR was identified in 23.0% of patients, without a significant temporal trend (p = 0.311). Most cases were classified as severe (75.4%), and piperacillin/tazobactam was the most commonly prescribed regimen (49.0%). Overall treatment concordance was 93.7%, with ceftriaxone exhibiting the highest discordance rate (14.9%).</p><p><strong>Conclusion: </strong>Ampicillin/sulbactam resistance rose markedly, while ciprofloxacin resistance decreased in our cohort. The change may be related to reduced fluoroquinolone prescribing and broader antimicrobial-use policy shifts in our institute, although this cannot be confirmed without institutional prescribing data. One in four children showed MDR isolates. Discordance was highest for ceftriaxone-based regimens, indicating that empiric antibiotic selection should be guided by local institutional susceptibility surveillance rather than a fixed choice of agent. Ongoing monitoring of institutional resistance is vital to support antibiotic stewardship in pediatric NTS enteritis.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"19 ","pages":"632613"},"PeriodicalIF":3.2000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13632619/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S632613","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Non-typhoidal Salmonella (NTS) enteritis is a major cause of infectious diarrhoea in children and increasing antibiotic resistance is limiting treatment effectiveness. There is limited longitudinal data on resistance development and on how well prescribing practices align with resistance patterns in hospitalised children. This study aimed to assess trends in antibiotic resistance, the prevalence of multidrug resistance (MDR), and treatment concordance over a decade from a single Chinese Centre.

Methods: The study included children with microbiologically confirmed NTS enteritis with available antibiotic susceptibility data. Resistance rates for 11 antibiotics were calculated, and temporal trends were analysed using the Cochran-Armitage trend test. MDR was defined as resistance to three or more antibiotic classes. Treatment concordance was assessed by comparing the empiric antibiotic class with in vitro susceptibility results.

Results: Of 486 records reviewed, 422 children were included. Infants under one year included 69.4% of cases. S. Typhimurium was the predominant serotype (58.8%). Ampicillin resistance was highest at 76.3%, followed by ampicillin/sulbactam (61.8%) and co-trimoxazole (34.8%). Ceftriaxone resistance was 28.4%. Ampicillin/sulbactam resistance increased significantly over the decade (44.4% to 65.3%; p = 0.010), while ciprofloxacin resistance declined (44.4% to 4.0%; p = 0.005). MDR was identified in 23.0% of patients, without a significant temporal trend (p = 0.311). Most cases were classified as severe (75.4%), and piperacillin/tazobactam was the most commonly prescribed regimen (49.0%). Overall treatment concordance was 93.7%, with ceftriaxone exhibiting the highest discordance rate (14.9%).

Conclusion: Ampicillin/sulbactam resistance rose markedly, while ciprofloxacin resistance decreased in our cohort. The change may be related to reduced fluoroquinolone prescribing and broader antimicrobial-use policy shifts in our institute, although this cannot be confirmed without institutional prescribing data. One in four children showed MDR isolates. Discordance was highest for ceftriaxone-based regimens, indicating that empiric antibiotic selection should be guided by local institutional susceptibility surveillance rather than a fixed choice of agent. Ongoing monitoring of institutional resistance is vital to support antibiotic stewardship in pediatric NTS enteritis.

儿童非伤寒沙门氏菌肠炎的抗生素耐药性趋势和处方模式:一项10年单中心回顾性研究。
背景:非伤寒沙门氏菌肠炎(NTS)是儿童感染性腹泻的主要原因,抗生素耐药性的增加限制了治疗效果。关于耐药性发展和处方做法与住院儿童耐药性模式的一致性的纵向数据有限。本研究旨在评估一个中国中心近十年来抗生素耐药性、多药耐药(MDR)患病率和治疗一致性的趋势。方法:研究纳入微生物学证实的NTS肠炎患儿,并提供抗生素敏感性数据。计算11种抗生素的耐药率,并采用Cochran-Armitage趋势检验分析时间趋势。耐多药被定义为对三种或三种以上抗生素类的耐药性。通过比较经验抗生素类别与体外药敏结果来评估治疗一致性。结果:在486份病历中,纳入422名儿童。1岁以下婴儿占69.4%。鼠伤寒沙门氏菌为主要血清型(58.8%)。氨苄西林耐药率最高,为76.3%,其次为氨苄西林/舒巴坦(61.8%)和复方新诺明(34.8%)。头孢曲松耐药28.4%。10年间,氨苄西林/舒巴坦耐药性显著上升(44.4% ~ 65.3%,p = 0.010),环丙沙星耐药性下降(44.4% ~ 4.0%,p = 0.005)。23.0%的患者存在多药耐药,无显著的时间趋势(p = 0.311)。大多数病例为重症(75.4%),哌拉西林/他唑巴坦是最常用的处方方案(49.0%)。总体治疗一致性为93.7%,其中头孢曲松治疗不一致性最高(14.9%)。结论:本组患者氨苄西林/舒巴坦耐药性明显上升,而环丙沙星耐药性下降。这一变化可能与我们研究所氟喹诺酮类药物处方减少和更广泛的抗菌素使用政策转变有关,尽管没有机构处方数据无法证实这一点。四分之一的儿童出现耐多药分离株。以头孢曲松为基础的方案的不一致性最高,表明经验性抗生素选择应以当地机构的药敏监测为指导,而不是固定的药物选择。持续监测机构耐药性对于支持儿科NTS肠炎的抗生素管理至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infection and Drug Resistance
Infection and Drug Resistance Medicine-Pharmacology (medical)
CiteScore
5.60
自引率
7.70%
发文量
826
审稿时长
16 weeks
期刊介绍: About Journal Editors Peer Reviewers Articles Article Publishing Charges Aims and Scope Call For Papers ISSN: 1178-6973 Editor-in-Chief: Professor Suresh Antony An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书